Richer JK - Search Results

1

MicroRNA regulation of epithelial plasticity in cancer.

D'Amato NC, Howe EN, Richer JK. D'Amato NC, et al. Among authors: richer jk. Cancer Lett. 2013 Nov 28;341(1):46-55. doi: 10.1016/j.canlet.2012.11.054. Epub 2012 Dec 8. Cancer Lett. 2013. PMID: 23228634 Review.

2

ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.

Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus RR, Richer JK. Singh M, et al. Among authors: richer jk. Mod Pathol. 2008 Jul;21(7):912-23. doi: 10.1038/modpathol.2008.82. Epub 2008 May 16. Mod Pathol. 2008. PMID: 18487993 Free article.

3

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.

Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK. Cochrane DR, et al. Among authors: richer jk. Mol Cancer Ther. 2009 May;8(5):1055-66. doi: 10.1158/1535-7163.MCT-08-1046. Epub 2009 May 12. Mol Cancer Ther. 2009. PMID: 19435871 Free PMC article.

4

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.

Cochrane DR, Howe EN, Spoelstra NS, Richer JK. Cochrane DR, et al. Among authors: richer jk. J Oncol. 2010;2010:821717. doi: 10.1155/2010/821717. Epub 2009 Dec 15. J Oncol. 2010. PMID: 20049172 Free PMC article.

5

Steroid receptors and microRNAs: relationships revealed.

Cochrane DR, Cittelly DM, Richer JK. Cochrane DR, et al. Among authors: richer jk. Steroids. 2011 Jan;76(1-2):1-10. doi: 10.1016/j.steroids.2010.11.003. Epub 2010 Nov 18. Steroids. 2011. PMID: 21093468 Review.

6

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

Cittelly DM, Das PM, Spoelstra NS, Edgerton SM, Richer JK, Thor AD, Jones FE. Cittelly DM, et al. Among authors: richer jk. Mol Cancer. 2010 Dec 20;9:317. doi: 10.1186/1476-4598-9-317. Mol Cancer. 2010. PMID: 21172025 Free PMC article.

7

Targets of miR-200c mediate suppression of cell motility and anoikis resistance.

Howe EN, Cochrane DR, Richer JK. Howe EN, et al. Among authors: richer jk. Breast Cancer Res. 2011 Apr 18;13(2):R45. doi: 10.1186/bcr2867. Breast Cancer Res. 2011. PMID: 21501518 Free PMC article.

8

MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.

Cochrane DR, Cittelly DM, Howe EN, Spoelstra NS, McKinsey EL, LaPara K, Elias A, Yee D, Richer JK. Cochrane DR, et al. Among authors: richer jk. Horm Cancer. 2010 Dec;1(6):306-19. doi: 10.1007/s12672-010-0043-5. Horm Cancer. 2010. PMID: 21761362 Free PMC article.

9

The role of miRNAs in progesterone action.

Cochrane DR, Spoelstra NS, Richer JK. Cochrane DR, et al. Among authors: richer jk. Mol Cell Endocrinol. 2012 Jun 24;357(1-2):50-9. doi: 10.1016/j.mce.2011.09.022. Epub 2011 Sep 17. Mol Cell Endocrinol. 2012. PMID: 21952083 Review.

10

Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.

Cochrane DR, Jacobsen BM, Connaghan KD, Howe EN, Bain DL, Richer JK. Cochrane DR, et al. Among authors: richer jk. Mol Cell Endocrinol. 2012 May 15;355(1):15-24. doi: 10.1016/j.mce.2011.12.020. Epub 2012 Jan 18. Mol Cell Endocrinol. 2012. PMID: 22330642 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page